Since then, some studies have examined the prognostic value of the AST/ALT ratio in various cancers, such as prostate cancer, oropharyngeal cancer, colorectal carcinoma, and HCC [9–11]. This evidence concerns the gene GPT and hepatocellular carcinoma.